Impact of sodium-glucose co-transporter 2 inhibition on right ventricular function and pulmonary artery systolic pressure across heart failure phenotypes: a meta-analytic approach
Bibliographic record
Abstract
Abstract Background Sodium-Glucose Co-Transporter 2 (SGLT-2) inhibitor has overwhelming evidence to improve left ventricular performance and remodeling in patients across heart failure (HF) phenotypes. However, its effects on the right ventricle (RV) and pulmonary artery systolic pressure (PASP) remain unclear. Objective To assess the impact of SGLT-2 inhibitor on RV function and PASP Study Selection: Studies reporting RV and PASP indices following SGLT-2 inhibitor treatment among HF patients were included in the analysis. Methods Relevant studies from January 2020 to January 2025 were searched using PubMed, Google Scholar, and Cochrane Library. The quality of included studies was assessed using the Newcastle-Ottawa scale. Variables were pooled using a random or fixed effects model to estimate weighted mean differences with 95% confidence interval. Restricted Maximum Likelihood method (REML) was used to assess heterogeneity. Results A total of 12 studies comprising 603 HF patients were eligible for analysis. Significant improvements on right ventricular function and pulmonary artery pressure after SGLT-2 inhibitor treatment were observed, including tricuspid annular plane systolic excursion (TAPSE) (weighted mean difference, 1.0 mm; 95% CI, 0.62, 1.38 mm; P < 0.00001), pulmonary artery systolic pressure (PASP) (weighted mean difference, -1/96 mmhg; 95% CI, -4.24, 0.32 mmhg; P=0.01), right ventricular fractional area change (RFAC) (weighted mean difference, 4.06; 95% CI, -1.33, 9.45; P<0.002), and right ventricular systolic excursion velocity (RV ‘s’) (weighted mean difference, 1.67 cm/s; 95% CI, -0.4, 3.75 cm/s; P<0.02). Quadratic regression model showed a significant correlation between TAPSE and left ventricular ejection fraction (LVEF) after excluding an outlier data. Conclusion The findings of the study demonstrate that SGLT-2 inhibitor improves RV performance and PASP in patients with HF irrespective of ejection fraction. This benefit is not entirely driven by the improvement in left ventricular function.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.022 | 0.039 |
| Meta-epidemiology (narrow) | 0.004 | 0.002 |
| Meta-epidemiology (broad) | 0.023 | 0.067 |
| Bibliometrics | 0.009 | 0.008 |
| Science and technology studies | 0.001 | 0.001 |
| Scholarly communication | 0.004 | 0.002 |
| Open science | 0.003 | 0.003 |
| Research integrity | 0.003 | 0.003 |
| Insufficient payload (model declined to judge) | 0.004 | 0.000 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".